OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Post‐transplant maintenance therapy in patients with FLT3‐mutated acute myeloid leukemia: Real‐world treatment patterns and outcomes
James D. Griffin, Yan Song, Hongbo Yang, et al.
European Journal Of Haematology (2021) Vol. 107, Iss. 5, pp. 553-565
Open Access | Times Cited: 14
James D. Griffin, Yan Song, Hongbo Yang, et al.
European Journal Of Haematology (2021) Vol. 107, Iss. 5, pp. 553-565
Open Access | Times Cited: 14
Showing 14 citing articles:
Mitochondrial abnormalities as a target of intervention in acute myeloid leukemia
Elissa Tjahjono, Megan R. Daneman, Bernadetta Meika, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Elissa Tjahjono, Megan R. Daneman, Bernadetta Meika, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Cytogenetic and molecular risk-driven conditioning intensity in acute myeloid leukemia patients undergoing stem cell transplantation with post-transplant cyclophosphamide: a study from the acute leukemia working party of the EBMT
Jaime Sanz, Myriam Labopin, Jurjen Versluis, et al.
Bone Marrow Transplantation (2025)
Closed Access
Jaime Sanz, Myriam Labopin, Jurjen Versluis, et al.
Bone Marrow Transplantation (2025)
Closed Access
Enhancing Therapeutic Efficacy of FLT3 Inhibitors with Combination Therapy for Treatment of Acute Myeloid Leukemia
Malia E. Leifheit, Gunnar Johnson, Timothy M. Kuzel, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9448-9448
Open Access | Times Cited: 3
Malia E. Leifheit, Gunnar Johnson, Timothy M. Kuzel, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9448-9448
Open Access | Times Cited: 3
Which FLT3 Inhibitor for Treatment of AML?
Jayastu Senapati, Tapan M. Kadia
Current Treatment Options in Oncology (2022) Vol. 23, Iss. 3, pp. 359-380
Closed Access | Times Cited: 12
Jayastu Senapati, Tapan M. Kadia
Current Treatment Options in Oncology (2022) Vol. 23, Iss. 3, pp. 359-380
Closed Access | Times Cited: 12
Salvage hematopoietic stem cell transplantation for patients with higher leukemia burden in relapsed or refractory acute myeloid leukemia: a ten-year study
Shan Jiang, Xuan Lu, Ruowen Wei, et al.
Annals of Hematology (2023) Vol. 102, Iss. 11, pp. 3205-3216
Closed Access | Times Cited: 5
Shan Jiang, Xuan Lu, Ruowen Wei, et al.
Annals of Hematology (2023) Vol. 102, Iss. 11, pp. 3205-3216
Closed Access | Times Cited: 5
Xinhong Fei, Shuqin Zhang, Jiangying Gu, et al.
Cancer Medicine (2022) Vol. 12, Iss. 6, pp. 6877-6888
Open Access | Times Cited: 8
FLT3 inhibitors and hematopoietic cell transplantation prolong survival in patients with FLT3-ITD-positive AML
Toshihiro Matsukawa, Masahiro Onozawa, Takeshi Kondo, et al.
Annals of Hematology (2024)
Closed Access | Times Cited: 1
Toshihiro Matsukawa, Masahiro Onozawa, Takeshi Kondo, et al.
Annals of Hematology (2024)
Closed Access | Times Cited: 1
SOHO State of the Art Updates and Next Questions |The Role of Maintenance Therapy in Acute Myeloid Leukemia
Rodrick Babakhanlou, Farhad Ravandi‐Kashani
Clinical Lymphoma Myeloma & Leukemia (2022) Vol. 23, Iss. 1, pp. 1-7
Closed Access | Times Cited: 5
Rodrick Babakhanlou, Farhad Ravandi‐Kashani
Clinical Lymphoma Myeloma & Leukemia (2022) Vol. 23, Iss. 1, pp. 1-7
Closed Access | Times Cited: 5
Clinical Outcomes and Treatment Patterns in Adults With FLT3-ITDmut+ Acute Myeloid Leukemia Undergoing Allogeneic Hemopoietic Cell Transplantation in the United States and Canada
Bhavik J. Pandya, Linda J. Burns, Tao Wang, et al.
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 7, pp. 683.e1-683.e13
Open Access
Bhavik J. Pandya, Linda J. Burns, Tao Wang, et al.
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 7, pp. 683.e1-683.e13
Open Access
Long-term remissions with Gilteritinib in early relapse after allogeneic stem cell transplantation of FLT3/NPM1 mutated acute myeloid leukemia
Edoardo Tamellini, Marco Sorio, A Andreini, et al.
BLOOD CELL THERAPY / The official journal of APBMT (2024) Vol. 7, Iss. 3
Open Access
Edoardo Tamellini, Marco Sorio, A Andreini, et al.
BLOOD CELL THERAPY / The official journal of APBMT (2024) Vol. 7, Iss. 3
Open Access
FLT3 inhibitors and hematopoietic cell transplantation prolong survival in patients with FLT3-ITD-positive AML
Toshihiro Matsukawa, Masahiro Onozawa, Takeshi Kondo, et al.
Research Square (Research Square) (2024)
Open Access
Toshihiro Matsukawa, Masahiro Onozawa, Takeshi Kondo, et al.
Research Square (Research Square) (2024)
Open Access
Depth of Response to Intensive Chemotherapy Has Significant Prognostic Value among Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation with Intermediate or Adverse Risk at Diagnosis Compared to At-Risk Group According to European Leukemia Net 2017 Risk Stratification
Tong Yoon Kim, Silvia Park, Daehun Kwag, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3199-3199
Open Access | Times Cited: 2
Tong Yoon Kim, Silvia Park, Daehun Kwag, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3199-3199
Open Access | Times Cited: 2
Post-allogeneic stem cell transplant FLT3- targeted maintenance therapy: updates and considerations for clinical practice
Jonathan Cohen, Richard T. Maziarz
Archives of Stem Cell and Therapy (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 1
Jonathan Cohen, Richard T. Maziarz
Archives of Stem Cell and Therapy (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 1
